<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10</volume><submitter>Abecasis AB</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Understanding HIV-1 subtype distribution and epidemiology can assist preventive measures and clinical decisions. Sequence variation may affect antiviral drug resistance development, disease progression, evolutionary rates and transmission routes.&lt;h4>Results&lt;/h4>We investigated the subtype distribution of HIV-1 in Europe and Israel in a representative sample of patients diagnosed between 2002 and 2005 and related it to the demographic data available. 2793 PRO-RT sequences were subtyped either with the REGA Subtyping tool or by a manual procedure that included phylogenetic tree and recombination analysis. The most prevalent subtypes/CRFs in our dataset were subtype B (66.1%), followed by sub-subtype A1 (6.9%), subtype C (6.8%) and CRF02_AG (4.7%). Substantial differences i</pubmed_abstract><journal>Retrovirology</journal><pagination>7</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3564855</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics.</pubmed_title><pmcid>PMC3564855</pmcid><pubmed_authors>Van de Vijver DA</pubmed_authors><pubmed_authors>Paredes R</pubmed_authors><pubmed_authors>Kolupajeva T</pubmed_authors><pubmed_authors>Asjo B</pubmed_authors><pubmed_authors>Beshkov D</pubmed_authors><pubmed_authors>Boucher CA</pubmed_authors><pubmed_authors>Wensing AM</pubmed_authors><pubmed_authors>Vercauteren J</pubmed_authors><pubmed_authors>Vandamme AM</pubmed_authors><pubmed_authors>Kucherer C</pubmed_authors><pubmed_authors>Theys K</pubmed_authors><pubmed_authors>Liitsola K</pubmed_authors><pubmed_authors>Abecasis AB</pubmed_authors><pubmed_authors>Camacho RJ</pubmed_authors><pubmed_authors>Grossman Z</pubmed_authors><pubmed_authors>Hamouda O</pubmed_authors><pubmed_authors>Horban A</pubmed_authors><pubmed_authors>Korn K</pubmed_authors><pubmed_authors>Otelea D</pubmed_authors><pubmed_authors>Nielsen C</pubmed_authors><pubmed_authors>Griskevicius A</pubmed_authors><pubmed_authors>Puchhammer-Stockl E</pubmed_authors><pubmed_authors>Struck D</pubmed_authors><pubmed_authors>Sonnerborg A</pubmed_authors><pubmed_authors>Paraskevis D</pubmed_authors><pubmed_authors>Schmit JC</pubmed_authors><pubmed_authors>Stanekova D</pubmed_authors><pubmed_authors>Linka M</pubmed_authors><pubmed_authors>Clotet B</pubmed_authors><pubmed_authors>Poljak M</pubmed_authors><pubmed_authors>Stanojevic M</pubmed_authors><pubmed_authors>Albert J</pubmed_authors><pubmed_authors>Balotta C</pubmed_authors><pubmed_authors>De Gascun C</pubmed_authors><pubmed_authors>Kostrikis LG</pubmed_authors></additional><is_claimable>false</is_claimable><name>HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics.</name><description>&lt;h4>Background&lt;/h4>Understanding HIV-1 subtype distribution and epidemiology can assist preventive measures and clinical decisions. Sequence variation may affect antiviral drug resistance development, disease progression, evolutionary rates and transmission routes.&lt;h4>Results&lt;/h4>We investigated the subtype distribution of HIV-1 in Europe and Israel in a representative sample of patients diagnosed between 2002 and 2005 and related it to the demographic data available. 2793 PRO-RT sequences were subtyped either with the REGA Subtyping tool or by a manual procedure that included phylogenetic tree and recombination analysis. The most prevalent subtypes/CRFs in our dataset were subtype B (66.1%), followed by sub-subtype A1 (6.9%), subtype C (6.8%) and CRF02_AG (4.7%). Substantial differences i</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Jan</publication><modification>2026-05-05T09:32:13.749Z</modification><creation>2026-04-07T21:38:42.632Z</creation></dates><accession>S-EPMC3564855</accession><cross_references><pubmed>23317093</pubmed><doi>10.1186/1742-4690-10-7</doi></cross_references></HashMap>